Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma, Non-Hodgkin 4Myelodysplastic Syndromes 3Triple Negative Breast Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Lymphoma 2Leukemia 2Hematologic Neoplasms 2Colonic Neoplasms 2Cardiovascular Diseases 2Cardiotoxicity 2Carcinoma in Situ 2Breast Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Peritoneal Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Nose Neoplasms 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1

Interventions

Electrocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brugada Syndrome × Electrocardiography × 1 year × Clear all
NCT07364656 2026-01-23

Analysis of the Presence and Cardiac Functional Effects of Anti-NaV1.5 Autoantibodies in Patients With Metastatic Tumors

IRCCS Policlinico S. Donato

Phase NA Not yet recruiting
196 enrolled
Gastrointestinal

Colonic Neoplasms, Brugada Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡